Recently Featured

Takeda Downsizes Boston Footprint Amid Consolidation Effort

February 19, 2026
Takeda Pharmaceutical Company has placed over 630,000 square feet of office space on the sublease market, signaling a significant shift in its operational strategy within the United States. This move is part of a broader consolidation effort as the Japanese biopharmaceutical giant prepares to centralize its U.S. corporate hub at a new development in Cambridge,…

MHRA Introduces Additional Restrictions for Use of the Chikungunya Vaccine (IXCHIQ)

February 19, 2026
The Medicines and Healthcare products Regulatory Agency (MHRA) has announced new restrictions regarding the administration of the Chikungunya vaccine, IXCHIQ. The updated guidance specifies that the vaccine should not be administered to individuals aged 60 and over, nor to those of any age with pre-existing conditions such as high blood pressure, heart disease, diabetes, or…

Sirio Pharma to Introduce First-in-Market Lutein Soft Chew for Eye Health

February 18, 2026
Sirio Pharma has partnered with OmniActive Health Technologies to launch a pioneering soft chew lutein supplement, featuring the award-winning Lutemax 2020 extract. This innovative product will be showcased at Natural Products Expo West, taking place from March 4-6 in Anaheim, where attendees can sample the new offering at Booth 3434. Lutemax 2020 is a patented…

Ongoing Cases